Antlerbio

Antlerbio

Enhancing productivity, efficiency and sustainability.

HQ location
Saggart, Ireland
Launch date
Employees
Enterprise value
$17—25m
  • Edit
DateInvestorsAmountRound
*

€3.8m

Seed
Total Funding000k
Notes (0)
More about Antlerbio
Made with AI
Edit

Antlerbio operates within the agricultural technology sector, providing a data analytics platform designed to enhance productivity and animal welfare in the dairy farming industry. Founded in 2020 by CEO Maria Jensen and CSO Nathalie Conte, the company leverages the founders' combined expertise in animal and human health, bioinformatics, and entrepreneurship. Jensen previously founded and sold a company focused on the genetics of elite racehorses, while Conte has over two decades of experience in cancer genetics and bioinformatics, applying concepts from human health to the animal sector.

The company's core offering is the EpiHerd platform, which analyzes gene expression data from dairy cows. This platform interprets how a cow's genes respond to environmental factors, nutrition, and health challenges, providing farmers with actionable insights. By using a combination of transcriptomics, epigenomics, and artificial intelligence, EpiHerd identifies subclinical stress and nutritional imbalances that may not be visibly apparent. This allows farmers to make proactive management decisions to optimize herd performance.

Antlerbio's business model is centered on providing this data-driven service to dairy farmers. The company operates in key European markets, including the UK, Finland, Sweden, and Denmark, serving over 100 farms. The service has demonstrated significant returns for its clients, with reported milk yield increases of up to 22%, a 6% rise in milk fat, and a 5% increase in milk protein. This leads to higher quality, more nutritious milk, which helps farmers secure better prices. The company reports an average return on investment for farmers of more than 7-to-1, driven by improved profitability, fertility, resilience, and overall herd wellbeing.

Financially, Antlerbio has successfully raised capital to scale its operations. A recent funding round led by The First Thirty Ventures, with participation from Endgame Capital and Generation-RE, brought the company's total raised funds to €7.2 million ($8.5 million), including grants. This capital is earmarked for expanding the EpiHerd system to thousands of farms across Europe, growing the team, and continuing to refine the technology.

Keywords: AgriTech, dairy farming, gene expression, animal health, bioinformatics, precision livestock farming, epigenetics, herd management, cattle analytics, milk yield, animal welfare, agricultural technology, livestock data, transcriptomics, sustainable agriculture, farm efficiency, bovine health, regenerative agriculture, nutritional imbalance, stress detection

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads